This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.

Acute and transient psychotic disorder, unspecified상세불명의 급성 및 일과성 정신병장애 (상세불명급성일과성정신병)

📋 Contents and key points
ItemDetails
A. Classification codesICD-10: F23.9 (Acute and transient psychotic disorder, unspecified) | Special Copayment Reduction: V161 (severe intractable disease, 5 years)
B. SynonymsBrief reactive psychosis NOS, reactive psychosis
C. Adult onsetPossibility of first presenting in adulthood Very high — onset in early adulthood (18-35 years) is most common, and because of the nature of a provisional diagnostic code it can be used at all ages.
1. HistoryLinked to the history of the concept of reactive psychosis; in ICD-10, F23.9 is the final residual code for acute psychotic episodes that do not fall under F23.0-F23.8 or cannot be classified because of insufficient information.
2. CausesPresumed common etiology of the F23 group; evaluation of cause limited by insufficient information; acute stress and neurobiological vulnerability are basic premises; organic causes have been excluded.
3. GeneticsPresumed to share the genetic characteristics of the F23 group; no genetic studies because of its nature as a provisional code; once the diagnosis is established, the genetic characteristics of that final diagnosis apply.
4. General epidemiologyFinal residual category of the F23 group; often used as a provisional diagnosis, making actual epidemiological estimates difficult; to be reclassified under another code after sufficient evaluation.
5. PathophysiologyCommon mechanism of the F23 group (dopamine hyperactivity, aberrant salience); specific mechanism cannot be identified because of insufficient information; understanding of the mechanism expands through additional information gathered during acute-phase treatment.
6. SymptomsAcute psychotic symptoms present but detailed classification not possible; one or more of delusions, hallucinations, and disorganization present; course expected to be under 3 months; provisional diagnostic status before sufficient evaluation.
7. SignsSigns of acute-onset psychosis (bizarre behavior, disorganized speech, confusion, agitation); detailed signs vary according to the main symptom type; thorough physical and psychiatric examination required.
8. ScreeningExclusion of organic causes is essential; structured assessment of psychotic symptoms; check the criteria for F23.0-F23.8; when information is insufficient, use F23.9 as a provisional code and then reassess.
9. DiagnosisF23.9 is a provisional or final residual diagnosis for when acute psychotic symptoms are present but there is not sufficient information or the case does not fall under F23.0-F23.8; establishing a reassessment plan is recommended.
10. TreatmentEnsuring safety and controlling symptoms in the acute phase (antipsychotics); symptom-focused treatment while gathering information for diagnostic reassessment; apply the standard treatment of the F23 group.
11. PrognosisPrognosis uncertain because of its nature as a provisional diagnosis; the generally favorable prognosis of the F23 group is provisionally applied; once the final diagnosis is established, the prognosis information for that diagnosis applies.
12. PreventionCommon prevention strategy of the F23 group; establishing an accurate diagnosis through reassessment is a prerequisite for formulating appropriate treatment and prevention plans.
13. ReferencesCastagnini A, Berrios GE. Acute and transient psychotic disorders: conceptual background and overview of research evidence. European Archives of Psychiatry and Clinical Neuroscience. 2009 … and 9 other papers

1. History

Acute and transient psychotic disorder, unspecified (F23.9) is the final residual (NOS, not otherwise specified) code in the ICD-10 F23 group for acute and transient psychotic episodes that do not fall under any of the detailed categories from F23.0 to F23.8, or for which detailed classification is not possible because there is not sufficient information at the time of evaluation.

Historically, the concept of 'reactive psychosis' developed in Scandinavian psychiatry and described acute psychotic episodes arising in response to clear psychosocial stress. In ICD-9 (1978), reactive psychosis (298.9 reactive psychosis, unspecified) existed as an explicit code. In DSM-III-R (1987) it was classified under the name Brief Reactive Psychosis, and in DSM-IV (1994) it was renamed Brief Psychotic Disorder, leaving the presence of acute stress only as a specifier.

ICD-10 (1992) merged these various acute psychosis concepts into the F23 group, subdivided it into F23.0-F23.8, and finally set F23.9 as the unspecified code. As synonyms of F23.9, ICD-10 specifies 'Brief reactive psychosis NOS' and 'Reactive psychosis.' This is for continuity with previous classification systems and shows that F23.9 is in effect the nonspecific residual category of the earlier concept.

In ICD-11 (2022), acute and transient psychotic disorder (6A23) was established as a single category, the former subclassification was abolished, and the unspecified code was consolidated into 6A2Z. The clinical reality that F23.9 is frequently used as a provisional diagnosis and research findings that detailed classification may undermine diagnostic reliability influenced the unification in ICD-11.


2. Causes

The cause of F23.9 is difficult to describe clearly given the nature of the code as one of insufficient information or inability to classify in detail. The etiological model of the entire F23 group applies as a basic premise.

Stress-vulnerability model: the etiological model of the entire F23 group, including F23.9, is the stress-vulnerability model. An acute psychotic episode occurs when an individual with congenital or acquired neurobiological vulnerability is exposed to acute environmental stress. This model applies to F23.9, but which specific combination of vulnerability and stress is involved has not been sufficiently evaluated.

Unclassifiable due to lack of information: the most common clinical situation in which F23.9 is used is when, at the time of acute-phase evaluation, sufficient history taking, collection of collateral information, and mental status examination have not been completed, so it cannot be determined whether the specific criteria of F23.0-F23.8 are met. F23.9 is used as a provisional code in initial evaluation in the emergency room, in acutely agitated states in which cooperation is difficult, and in patients who cannot communicate.

Culture-specific acute psychosis: acute psychotic episodes seen in some cultures (amok, koro, latah, piblokto, etc.) may be classified as F23.9 when they do not clearly fit F23.0-F23.8 of ICD-10. The cause of such culture-related acute psychosis is explained by the combined action of cultural stress, social expectations, and biological vulnerability. In Korea, cases of hwa-byung accompanied by acute psychotic features may be classified as F23.9.

Confirming exclusion of organic causes: for all codes of the F23 group including F23.9, the first thing to exclude is an organic cause. F23.9 is applied after organic causes such as encephalitis, brain tumor, metabolic abnormality, and substance induction have been excluded, so F23.9 is a code that already presupposes a functional acute psychosis.


3. Genetics

Because F23.9 is a provisional or residual code, no independent genetic studies exist. The genetic characteristics of the entire F23 group are provisionally applied.

Genetic heterogeneity of the F23 group: genetic studies of acute and transient psychosis show that this category is genetically heterogeneous. Some cases share the genetic vulnerability of schizophrenia, some share that of mood disorders, and some may have a distinct genetic profile. When the final diagnosis is established during follow-up in a patient diagnosed with F23.9, the genetic characteristics corresponding to that diagnosis apply.

Importance of clinical genetic assessment: taking a family history is clinically important even in patients with F23.9. A family history of schizophrenia spectrum disorder, bipolar disorder, major depressive disorder, or delusional disorder is useful for predicting in which direction an F23.9 episode will evolve. If there is a strong family history of schizophrenia, the F23.9 episode is likely to be an early manifestation of schizophrenia, and if there is a family history of bipolar disorder, it may be part of psychosis accompanying a manic episode.

Directions for future research: if long-term follow-up studies of patients diagnosed with F23.9 analyze the relationship between the distribution of final diagnoses and genetic characteristics, it would help in understanding the actual components of the provisional diagnosis F23.9. Such research is also one of the backgrounds for the abolition of the subclassification in ICD-11.


4. General epidemiology

The epidemiology of F23.9 is difficult to grasp owing to the nature of a provisional and residual code.

Frequency of use: in clinical practice, F23.9 is frequently used as a provisional diagnosis in initial evaluation in the acute phase. After sufficient evaluation it is reclassified into another F23 subcode or another diagnosis (F20, F31, etc.). Therefore the frequency of F23.9 use in claims data reflects the characteristics of the diagnostic process more than the frequency of the actual clinical entity.

Epidemiology of the F23 group as a whole: the annual incidence of the F23 group as a whole is estimated at 4-9 per 100,000 population. Scandinavian cohort studies, the UK ÆSOP study, Indian studies, and others show consistent results. F23.9 may account for a considerable part of the F23 group, but the fact that a large proportion of these transition to other diagnoses during follow-up complicates epidemiological interpretation.

Age of onset and sex: as with the characteristics of the F23 group as a whole, F23.9 is estimated to have frequent onset in early adulthood (18-35 years) with a slight female predominance. However, because of its nature as a provisional code, F23.9 can be used as a provisional code before sufficient evaluation at all ages including adolescents and middle-aged and older adults, so it is difficult to determine the age distribution.


5. Pathophysiology

For the pathophysiology of F23.9, the common mechanisms of the F23 group as a whole apply, but because it is before sufficient evaluation, it is difficult to identify specific mechanisms.

Acute dopamine hyperactivity: the basic mechanism applied is that a surge of mesolimbic dopamine due to acute stress or vulnerability predisposition causes aberrant salience, producing psychotic symptoms such as delusions and hallucinations. This mechanism is also supported therapeutically in that antipsychotics relieve symptoms by suppressing this process through D2 receptor blockade.

Diagnostic uncertainty and limits of understanding the mechanism: at the point when F23.9 is used as a provisional diagnosis, sufficient history information, identification of the symptom pattern, and confirmation of precipitating factors have not been completed, so it is difficult to describe a specific pathophysiology systematically. Understanding of the mechanism is deepened through the information-gathering process that proceeds simultaneously with acute-phase treatment, and the diagnosis is reclassified on that basis.

Neuroinflammation and acute psychosis: recent studies are accumulating evidence that neuroinflammation (microglial activation, increased inflammatory cytokines) may be involved in acute psychotic episodes. This applies to the F23 group as a whole, and in some F23.9 cases the neuroinflammatory mechanism may play the main role. When autoimmune encephalitis (anti-NMDA receptor encephalitis, etc.) presents with acute psychotic features, it should be classified as an organic cause (F06), but it may be provisionally classified as F23.9 at initial evaluation.


6. Symptoms

The symptoms of F23.9 are, by definition, a state in which acute psychotic symptoms are present but it has not been determined whether the detailed criteria of a specific F23 subcategory are met.

Presence of acute psychotic symptoms: a state in which one or more psychotic symptoms such as delusions, hallucinations, severely disorganized speech or behavior, and catatonia are present with acute onset (peaking within 2 weeks). The presence of these symptoms is confirmed, but evaluation of detailed characteristics, such as which symptom is predominant, whether polymorphic features are present, and whether schizophrenia-specific symptoms are present, has not been completed.

Incomplete evaluation or atypical symptoms: another situation in which F23.9 is used is when the symptom pattern does not exactly fit any of the criteria of F23.0-F23.8. Examples include borderline polymorphic features, cases in which delusions and hallucinations are mixed in equal proportion yet the criteria for schizophrenia are not met, and cases in which clinical information is insufficient even to place it in F23.8.

Course: by definition of acute and transient psychosis, the entire episode must be under 3 months. F23.9 is a state that meets this duration requirement but has not been classified in detail. If symptoms persist for 3 months or more, F23.9 cannot be maintained, and reclassification into schizophrenia (F20), schizoaffective disorder (F25), a mood disorder (F30-F39), or persistent delusional disorder (F22), etc., is needed.


7. Signs

The clinical signs seen in F23.9 patients include the common signs of acute-onset psychosis and mixed, atypical behavioral changes that are difficult to classify into any specific type.

Common signs of acute onset: the abrupt emergence of behavior and speech markedly different from usual is the most characteristic sign of F23.9. Sudden confusion, intense agitation or restlessness, bizarre or incomprehensible speech, muttering to oneself or responding to something unseen, complete refusal to sleep, and refusal of food and fluids may appear. An important clinical characteristic is that these signs appear suddenly within hours to days.

Safety risk signs: during an acute psychotic episode there may be a risk of self-harm (delusion-based attempts at self-injury, accidents occurring while fleeing from noises or voices), risk of harm to others (aggressive behavior due to persecutory delusions), and risk of accidents (traffic accidents due to disorganized judgment, etc.). Safety assessment in the acute phase is the top priority.

Physical signs: during an acute psychotic episode, physical symptoms due to sleep deprivation (fatigue, dehydration, electrolyte abnormalities) and nutritional problems due to food refusal may accompany. Fever may suggest an organic cause (encephalitis, etc.), so physical examination is essential. When catatonia accompanies, there is a risk of physical complications (pressure sores, pneumonia, deep vein thrombosis).


8. Screening

Since the situation in which F23.9 is used is itself one in which sufficient evaluation has not yet been done or detailed classification is not possible, the purpose of screening tests is to exclude organic causes and to gather information for accurate classification later.

Urgent tests to exclude organic causes: (1) blood tests: CBC, blood glucose, electrolytes, renal function, liver function, thyroid function, CRP/ESR, blood culture (if febrile); (2) urine tests: urinalysis, toxicology screen; (3) brain imaging: head CT (rapid evaluation in the acute phase) or MRI (when encephalitis is suspected); (4) EEG (when a postictal state is suspected); (5) cerebrospinal fluid test (anti-NMDA receptor antibody and CSF pleocytosis check when autoimmune or infectious encephalitis is suspected).

Mental status examination: after acute-phase agitation or noncooperation subsides, a structured mental status examination is performed. It includes assessment of the content and type of delusions, type of hallucinations (auditory, visual, somatic, etc.), abnormalities of thought form (loosening of associations, derailment), and signs of catatonia. Based on these results, whether the criteria for F23.0-F23.8 are met is checked sequentially.

Collecting collateral information: history taking from family, cohabitants, co-workers, and others often provides decisive information. It is important to confirm the time of onset, the pattern of symptom emergence, preceding stressful events, past psychiatric history, medication history, and substance use history.


9. Diagnosis

F23.9 is a residual code used after confirming that acute psychotic symptoms are present when information for detailed classification is insufficient or the case does not fall under any of F23.0-F23.8.

Conditions for applying the ICD-10 F23.9 diagnosis: (1) presence of acute-onset psychotic symptoms (one or more of delusions, hallucinations, disorganization); (2) exclusion of organic causes (completion of exclusion tests or clinical judgment); (3) does not meet, or cannot be judged against, each criterion of F23.0-F23.8; (4) does not meet, or cannot be judged against, the criteria for schizophrenia (F20) and mood disorders (F30-F39); (5) presence of acute-onset characteristics. It can be used even in a provisional state in which (2)-(4) have not been fully evaluated, but should transition to an accurate classification as early as possible.

Obligation to reassess: F23.9 is a provisional or final residual code, and a clinician who sets the diagnosis as F23.9 must explicitly establish a future reassessment plan. After sufficient history information is collected, or after stabilization of the acute phase, classification into F23.0-F23.8 or another diagnosis is attempted through mental status examination.

ICD-11 corresponding code: in ICD-11 it was unified as acute and transient psychotic disorder (6A23), and the unspecified code is 6A2Z (primary psychotic disorder, unspecified). On transition to ICD-11, F23.9 is mapped to 6A23 or 6A2Z.


10. Treatment

Treatment of F23.9 is structured so that ensuring safety in the acute phase, controlling symptoms, and diagnostic reassessment proceed simultaneously.

Ensuring safety in the acute phase: when there is a risk of harm to self or others, a safe environment (hospitalization or close observation) is the top priority. In emergencies, involuntary admission is considered even without patient consent, and this is also necessary for the patient's safety and for tests to exclude organic causes.

Acute-phase drug treatment: second-generation antipsychotics (olanzapine, risperidone, aripiprazole, quetiapine) are the first choice. For acute agitation, intramuscular formulations (olanzapine IM, haloperidol IM + lorazepam IM) can be used. When catatonia accompanies, lorazepam is given first and caution is needed with antipsychotic monotherapy. Because the diagnosis has not been confirmed, treatment is started at a low starting dose and adjusted while observing the response.

In parallel with diagnostic reassessment: while acute-phase treatment is started, sufficient history information, laboratory tests, and additional mental status examinations are carried out at the same time. Once acute agitation subsides and cooperation becomes possible, reclassification into F23.0-F23.8 or into another diagnostic group is attempted through a structured interview. Once the diagnosis is confirmed, treatment switches to the corresponding treatment plan.


11. Prognosis

The prognosis of F23.9 is uncertain because of the provisional or residual nature of the code, but the generally favorable prognosis of the F23 group is provisionally applied.

Prognosis of the F23 group as a whole: in long-term follow-up studies of acute and transient psychosis, about 70-80% of patients achieve good functional recovery within 2 years after the first episode. Mortality is similar to the general population, and suicide risk is lower than in schizophrenia. However, in about 30-40% of patients the diagnosis changes over the long term, with transition to schizophrenia, schizoaffective disorder, or mood disorders, in which case the prognosis differs from that at the time of the initial F23.9 diagnosis.

Prognostic factors: factors associated with good prognosis are good premorbid functioning, a clear precipitating stressor, acute onset (within 2 weeks), short duration of untreated psychosis (DUP), female sex, and strong social support. Factors associated with poor prognosis are poor premorbid functioning, a strong family history of schizophrenia, long DUP, male sex, and low socioeconomic status.

Change in prognosis with diagnostic transition: if a patient provisionally diagnosed with F23.9 is eventually reclassified as schizophrenia, the prognosis differs markedly. Because early diagnosis of schizophrenia and intensive treatment are important for improving long-term functional prognosis, it is essential to maintain active follow-up even during the period of the provisional F23.9 diagnosis.


12. Prevention

Prevention of F23.9 includes the acute psychosis prevention strategies common to the F23 group as a whole and strengthening the clinical system for accurate diagnosis.

Primary prevention of acute psychosis: acute stress management, sleep hygiene education, and prevention of substance use (psychosis-inducing substances such as amphetamines and cannabis) are the general primary prevention strategies. There is evidence that intervention programs for the at-risk mental state (ARMS) are somewhat effective.

Early detection and prompt specialist evaluation: to reduce use of the provisional code F23.9, a service system is needed in which prompt and sufficient specialist mental health evaluation can be performed when an acute psychotic episode occurs. Applying a standardized acute psychosis assessment protocol in the emergency room or crisis assessment center contributes to appropriate classification into F23.0-F23.8 and to minimizing the use of the provisional code F23.9.

Prevention of relapse and chronicity: after the first episode, education on medication adherence for relapse prevention, education on recognizing early warning signs of relapse, and establishing a crisis response plan are important. After the final diagnosis is established from F23.9, the relapse prevention strategy appropriate to that diagnosis is applied. Regular follow-up is needed to update the treatment plan according to changes in diagnosis.


13. References

  1. Castagnini A, Berrios GE. Acute and transient psychotic disorders: conceptual background and overview of research evidence. European Archives of Psychiatry and Clinical Neuroscience. 2009;259(8):433–443. doi:10.1007/s00406-009-0013-4
  2. Pillmann F, Marneros A. Longitudinal follow-up in acute and transient psychotic disorders and schizophrenia. British Journal of Psychiatry. 2005;187:286–287. doi:10.1192/bjp.187.3.286
  3. Singh SP, Burns T, Amin S, Jones PB, Harrison G. Acute and transient psychotic disorders: precursors, epidemiology, course and outcome. British Journal of Psychiatry. 2004;185:452–459. doi:10.1192/bjp.185.6.452
  4. Pillmann F, Haring A, Balzuweit S, Blöink R, Marneros A. The concordance of ICD-10 acute and transient psychosis and DSM-IV brief psychotic disorder. Psychological Medicine. 2002;32(3):525–533. doi:10.1017/S0033291701004913
  5. Marneros A, Pillmann F. Acute and Transient Psychoses. Cambridge: Cambridge University Press; 2004.
  6. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: WHO; 1992.
  7. Jäger M, Bottlender R, Strauss A, Möller HJ. On the descriptive validity of ICD-10 schizophrenia: empirical analyses in the spectrum of non-affective functional psychoses. Psychopathology. 2003;36(3):152–159. doi:10.1159/000071259
  8. Malhotra S, Varma VK, Malhotra A, Spring B, Chaturvedi SK. Outcome of acute-onset psychosis: a follow-up study from India. British Journal of Psychiatry. 1998;172:411–417. doi:10.1192/bjp.172.5.411
  9. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Washington DC: APA; 2013.
  10. Correll CU, Hauser M, Auther AM, Cornblatt BA. Research in people with psychosis risk syndrome: a review of the current evidence and future directions. Journal of Child Psychology and Psychiatry. 2010;51(4):390–431. doi:10.1111/j.1469-7610.2010.02235.x